Mid-Term Impact of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure.

Hannappe, Marc-Antoine; Baudin, Florian; Mariet, Anne-Sophie; Gabrielle, Pierre-Henri; Arnould, Louis; Bron, Alain M; Creuzot-Garcher, Catherine.

Afiliação

Hannappe MA; Ophthalmology Department, University Hospital of Dijon, 21000 Dijon, France.
Baudin F; Ophthalmology Department, University Hospital of Dijon, 21000 Dijon, France.
Mariet AS; Physiopathologie et Epidémiologie Cérébro-Cardiovasculaires (PEC2, EA 7460), Burgundy University, 21000 Dijon, France.
Gabrielle PH; INSERM, CIC 1432, Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, Burgundy University, 21000 Dijon, France.
Arnould L; INSERM, CIC 1432, Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, Burgundy University, 21000 Dijon, France.
Bron AM; Service de Biostatistique et d'Informatique Médicale (DIM), University Hospital of Dijon, 21000 Dijon, France.
Creuzot-Garcher C; Ophthalmology Department, University Hospital of Dijon, 21000 Dijon, France.

J Clin Med ; 11(4)2022 Feb 11.

Article em En | MEDLINE | ID: mdl-35207218